Aging of the brain is characterized by deleterious processes at various levels including cellular/molecular and ...
Lu]Lu-PSMA-617 radiopharmaceutical therapy has been approved for the treatment of men with metastatic castration-resistant ...
Giri et al. present a case report involving a patient with metachronous low-volume metastatic hormone-sensitive prostate cancer (mHSPC) who declined standard treatments such as androgen deprivation ...
Journal of Nuclear Medicine August 2025, jnumed.125.270130; DOI: https://doi.org/10.2967/jnumed.125.270130 ...
This information for authors presents editorial standards that pertain to The Journal of Nuclear Medicine (JNM). To submit an article to JNM, please go to: https://submit-jnm.snmjournals.org. ARTICLE ...
177 Lu-PSMA-617 Monotherapy Is Provocative but No Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer ...
The annual Journal Citation Reports includes several statistics and figures, the key figure being journal impact factor. Journal impact factor, despite being widely used, is not well understood. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback